Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort study.

Raphael BorieLaurent SavaleAntoine DossierJade GhosnCamille TailléBenoit VisseauxKamel JebreenAbourahmane DialloChloe TesmoingtLise MorerTiphaine GolettoNathalie FaucherLinda HajoujiCatherine NeukirchMathilde PhillipsSandrine StelianidesLila BouadmaSolenn BrosseauSébastien OttavianiJohan PluvyDiane Le PluartMarie-Pierre DebrayAgathe Raynaud-SimonDiane DescampsAntoine KhalilJean Francois TimsitFrancois-Xavier LescureVincent DescampsThomas PapoMarc HumbertBruno CrestaniPhilippe DieudeEric VicautGérard Zalcmannull null

Published in: PloS one (2020)

In COVID-19 non-ICU inpatients at the cytokine release phase, corticosteroids with or without anakinra were associated with a 30% decrease of death risk on Day 15.

Keyphrases

low dose
intensive care unit
coronavirus disease
mechanical ventilation
sars cov
high dose
early onset
acute respiratory distress syndrome